Eduardo Anguita

9PUBLICATIONS
76CO-AUTHORS
Molecular targetsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer therapy (excl. chemotherapy and radiation therapy)AutoimmunityMedical molecular engineering of nucleic acids and proteins
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|May 11, 2024
Tigecycline Opposes Bortezomib Effect on Myeloma Cells Decreasing Mitochondrial Reactive Oxygen Species Production.

Carlos Ramos-Acosta, Laura Huerta-Pantoja, Milton Eduardo Salazar-Hidalgo

|Feb 14, 2024
Engineered T cells secreting anti-BCMA T cell engagers control multiple myeloma and promote immune memory in vivo.

Laura Díez-Alonso, Aïda Falgas, Javier Arroyo-Ródenas

|Feb 10, 2024
e14a2 Transcript Favors Treatment-Free Remission in Chronic Myeloid Leukemia When Associated with Longer Treatment with Tyrosine Kinase Inhibitors and Sustained Deep Molecular Response.

Sílvia Marcé, Aleix Méndez, Blanca Xicoy

|May 16, 2023
Specific Cellular and Humoral Immune Responses to the Neoantigen RBD of SARS-CoV-2 in Patients with Primary and Secondary Immunodeficiency and Healthy Donors.

Kauzar Mohamed Mohamed, Kissy Guevara-Hoyer, Carlos Jiménez García

|Dec 23, 2022
An NMR-Based Model to Investigate the Metabolic Phenoreversion of COVID-19 Patients throughout a Longitudinal Study.

Rubén Gil-Redondo, Ricardo Conde, Maider Bizkarguenaga

|Sep 01, 2021
Engraftment characterization of risk-stratified AML in NSGS mice.

Rafael Díaz de la Guardia, Talía Velasco-Hernandez, Francisco Gutiérrez-Agüera

Pageof 2

Frequent Collaborators

2 joint publications

Sílvia Marcé

2 joint publications

Juan Carlos Hernández-Boluda

2 joint publications

Silvia Escribano Serrat

1 joint publications

Concepción Boqué